15-03-2023, 13:22

MCH Group | Ad hoc announcement pursuant to Art. 53 LR |

Raphael Wyniger to join the Board of Directors of the MCH Group The Executive Council of the Canton of Basel-Stadt has
Globe Newswire
14-03-2023, 19:46

Roche Annual General Meeting 2023

All proposals of the Board of Directors approvedSeverin Schwan elected as new Chairman of the Board of Directors; all
Globe Newswire
10-03-2023, 06:48

FDA Advisory Committee votes in favour of the clinical

U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX
Globe Newswire
8-03-2023, 22:32

Celebrating International Women's Day, OISTE.ORG and

Celebrating International Women's Day, OISTE.ORG and WISe.ART will Raise Funds for the Nuevo Hogar Begoña NGO, During
Globe Newswire
7-03-2023, 13:10

WISe.ART Allows Artist to Showcase Their NFT Collection of

WISe.ART Allows Artist to Showcase Their NFT Collection of Art Created by Artificial Intelligence Algorithms GENEVA /
Globe Newswire
28-02-2023, 14:03

Record number of orders received and strong sales growth

Ad hoc announcement pursuant to Art. 53 KR Despite a very challenging market environment, the Feintool Group
Globe Newswire
24-02-2023, 13:05

2023 ANNUAL GENERAL MEETING OF SIKA AG

2023 ANNUAL GENERAL MEETING OF SIKA AG The Board of Directors confirms March 28, 2023 as date for the Annual General
Globe Newswire
23-02-2023, 13:10

Roche launches two new antibodies to identify key clinical

Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations in
Globe Newswire
21-02-2023, 13:09

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical

KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire
20-02-2023, 13:20

Novartis announces the appointment of the

Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the
Globe Newswire